Enrollment ongoing in Phase 2 KOURAGE trial of Auxora in acute kidney injury (AKI) with respiratory failure; data expected in 1H 2026 Positive discussions with FDA ...
Cohorts 1 and 2 are fully enrolledPMN310 continues to demonstrate a favorable safety profileOn track to report 6-month interim data in Q2 2026 ...
Stockton Council's cabinet is being asked to approve the three high-value contracts at its next meeting this week ...
Community practices may offer more accessibility and continuity of care, whereas academic centers may be better suited for complex cases or clinical trial enrollment. They emphasize the importance of ...
A novel oral therapy that inhibits the interleukin-23 inflammatory pathway provided control of moderate-to-severe psoriasis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback